Cargando…

Paradoxes of the EphB1 receptor in malignant brain tumors

Eph receptors are a subfamily of receptor tyrosine kinases. Eph receptor-mediated forward and ephrin ligand-mediated reverse signalings are termed bidirectional signaling. Increasing evidence shows that Eph/ephrin signaling regulates cell migration, adhesion, morphological changes, differentiation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wenqiang, Wang, Hongju, Ji, Shaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299699/
https://www.ncbi.nlm.nih.gov/pubmed/28194092
http://dx.doi.org/10.1186/s12935-017-0384-z
_version_ 1782506077043032064
author Wei, Wenqiang
Wang, Hongju
Ji, Shaoping
author_facet Wei, Wenqiang
Wang, Hongju
Ji, Shaoping
author_sort Wei, Wenqiang
collection PubMed
description Eph receptors are a subfamily of receptor tyrosine kinases. Eph receptor-mediated forward and ephrin ligand-mediated reverse signalings are termed bidirectional signaling. Increasing evidence shows that Eph/ephrin signaling regulates cell migration, adhesion, morphological changes, differentiation, proliferation and survival through cell–cell communication. Some recent studies have started to implicate Eph/ephrin signaling in tumorigenesis, metastasis, and angiogenesis. Previous studies have shown that EphB1 receptor and its ephrin ligands are expressed in the central nervous system. EphB1/ephrin signaling plays an important role in the regulation of synapse formation and maturation, migration of neural progenitors, establishment of tissue patterns, and the development of immune organs. Besides, various recent studies have detected the abnormal expression of EphB1 receptor in different brain tumors. However, the underlying molecular mechanisms of EphB1/ephrins signaling in the development of these tumors are not fully understood. This review focuses on EphB1 that has both tumor-suppressing and -promoting roles in some brain tumors. Understanding the intracellular mechanisms of EphB1 in tumorigenesis and metastasis of brain tumors might provide a foundation for the development of EphB1-targeted therapies.
format Online
Article
Text
id pubmed-5299699
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52996992017-02-13 Paradoxes of the EphB1 receptor in malignant brain tumors Wei, Wenqiang Wang, Hongju Ji, Shaoping Cancer Cell Int Review Eph receptors are a subfamily of receptor tyrosine kinases. Eph receptor-mediated forward and ephrin ligand-mediated reverse signalings are termed bidirectional signaling. Increasing evidence shows that Eph/ephrin signaling regulates cell migration, adhesion, morphological changes, differentiation, proliferation and survival through cell–cell communication. Some recent studies have started to implicate Eph/ephrin signaling in tumorigenesis, metastasis, and angiogenesis. Previous studies have shown that EphB1 receptor and its ephrin ligands are expressed in the central nervous system. EphB1/ephrin signaling plays an important role in the regulation of synapse formation and maturation, migration of neural progenitors, establishment of tissue patterns, and the development of immune organs. Besides, various recent studies have detected the abnormal expression of EphB1 receptor in different brain tumors. However, the underlying molecular mechanisms of EphB1/ephrins signaling in the development of these tumors are not fully understood. This review focuses on EphB1 that has both tumor-suppressing and -promoting roles in some brain tumors. Understanding the intracellular mechanisms of EphB1 in tumorigenesis and metastasis of brain tumors might provide a foundation for the development of EphB1-targeted therapies. BioMed Central 2017-02-08 /pmc/articles/PMC5299699/ /pubmed/28194092 http://dx.doi.org/10.1186/s12935-017-0384-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Wei, Wenqiang
Wang, Hongju
Ji, Shaoping
Paradoxes of the EphB1 receptor in malignant brain tumors
title Paradoxes of the EphB1 receptor in malignant brain tumors
title_full Paradoxes of the EphB1 receptor in malignant brain tumors
title_fullStr Paradoxes of the EphB1 receptor in malignant brain tumors
title_full_unstemmed Paradoxes of the EphB1 receptor in malignant brain tumors
title_short Paradoxes of the EphB1 receptor in malignant brain tumors
title_sort paradoxes of the ephb1 receptor in malignant brain tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299699/
https://www.ncbi.nlm.nih.gov/pubmed/28194092
http://dx.doi.org/10.1186/s12935-017-0384-z
work_keys_str_mv AT weiwenqiang paradoxesoftheephb1receptorinmalignantbraintumors
AT wanghongju paradoxesoftheephb1receptorinmalignantbraintumors
AT jishaoping paradoxesoftheephb1receptorinmalignantbraintumors